High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controls-Reference-Cited by-同舟云学术

High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controls

Published:2003-01 Issue:1 Volume:98 Page:145-149
ISSN:0074-0276
Container-title:Memórias do Instituto Oswaldo Cruz
language:
Short-container-title:Mem. Inst. Oswaldo Cruz

Author:

Romero Gustavo Adolfo Sierra¹,Flores Érico Marlon de Moraes²,Noronha Elza Ferreira¹,Macêdo Vanize de Oliveira¹

Affiliation:

1. Universidade de Brasília, Brasil

2. Universidade Federal de Santa Maria, Brasil

Publisher

FapUNIFESP (SciELO)

Subject

Microbiology (medical)

Link

http://www.scielo.br/pdf/mioc/v98n1/v98n1a19.pdf

Reference27 articles.

1. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis;Ballou WR;Lancet,1987

2. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years;Berman JD;Clin Infect Dis,1997

3. Antimoniato de meglumina;Rev Soc Bras Med Trop,2001

4. Contact allergy to metals and their salts: 3;Cavelier C;Other metals. Derm Beruf Umwelt,1995

5. Pharmacokinetics of antimony during treatment of visceral leishmamiasis with sodium stibogluconate or meglumine antimoniate;Chulay JD;Trans R Soc Trop Med Hyg,1988

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fat necrosis: A neglected side effect of intramuscular injections;Clinical Case Reports;2022-06

2. Perceptions on therapeutic modalities regarding the virulence and immunity of cutaneous leishmaniasis;Parasitologists United Journal;2021-12-01

3. In Vitro and In Vivo Anti-parasitic Activity of Artemisinin Combined With Glucantime and Shark Cartilage Extract on Iranian Strain of Leishmania major (MRHO/IR/75/ER);Jundishapur Journal of Microbiology;2021-06-19

4. Profil d’acceptabilité de l’antimoniate de méglumine (Glucantime®) par voie parentérale chez le nourrisson traité pour leishmaniose cutanée;Therapies;2020-05

5. Antimony and Nickel;Critical Care Toxicology;2017